Sector ratings GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 06:01:12 2026-07-24 EDT			5-day change	1st Jan Change
2,513.25 ^INR	+0.76%		+2.37%	+1.71%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	4.42B	-	-	-		-
ELI LILLY AND COMPANY	1,067B		A
JOHNSON & JOHNSON	635B		BBB
ABBVIE INC.	458B		AA	-
ROCHE HOLDING AG	347B		AA
NOVARTIS AG	295B		AAA
ASTRAZENECA PLC	262B		A
NOVO NORDISK A/S	216B		A
AMGEN INC.	203B		A
GILEAD SCIENCES, INC.	161B		AA
PFIZER INC.	140B		A
BRISTOL-MYERS SQUIBB COMPANY	127B		A
VERTEX PHARMACEUTICALS INCORPORATED	121B		AA
SANOFI	104B		AA
GSK PLC	102B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	74.54B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
TAKEDA PHARMACEUTICAL COMPANY LIMITED	55.09B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	52.08B		AA
BAYER AG	51.52B		AA
Average	226.91B		AA
Weighted average by Cap.			AA